Skip to main content

Table 2 Pooled estimates for IOPR from baseline for Ahmed versus Baerveldt

From: The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis

 

No. of studies

WMD(random)(95 % CI)

Test for heterogeneity

Test for overall effect

6 months

 All trials

5

1.58 (−2.99, 6.15)

Q =83.02, P <0.001

Z =0.68, P =0.499

 Retro

3

2.52 (−4.81, 9.84)

Q =31.53, P <0.001

Z =0.67, P =0.500

 RCT

2

0.06 (−1.34, 1.45)

Q =0.83, P =0.362

Z =0.08, P =0.937

12 months

 All trials

6

−1.01 (−3.40, 1.98)

Q =35.80, P <0.001

Z =0.66, P =0.509

 Retro

4

0.29 (−3.12,3.70)

Q =12.12, P =0.007

Z =0.17, P =0.869

 RCT

2

−3.16 (−4.86,−1.45)

Q =0.16, P =0.687

Z =3.63, P <0.001

24 months

 All trials

3

−0.54 (−4.89, 3.82)

Q = 21.78, P <0.001

Z =0.24, P =0.809

 Retro

2

0.28 (−5.68, 6.24)

Q = 10.11, P =0.001

Z = 0.09, P =0.926

 RCT

1

−2.27 (−4.68, 0.14)

-

Z =1.85, P =0.065

36 months

 All trials

2

−0.47 (−3.29, 2.35)

Q = 4.44, P =0.035

Z = 0.32, P =0.746

 Retro

1

0.80 (−0.46, 2.06)

-

Z = 1.24, P =0.215

 RCT

1

−2.10 (−4.48, 0.28)

-

Z = 1.73, P =0.084

  1. IOPR intraocular pressure reduction, WMD weighted mean differences, CI confidence interval, Retro retrospective comparative study, RCT prospective randomized controlled trial